1. Home
  2. F vs NTRA Comparison

F vs NTRA Comparison

Compare F & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ford Motor Company

F

Ford Motor Company

N/A

Current Price

$13.36

Market Cap

55.2B

ML Signal

N/A

Logo Natera Inc.

NTRA

Natera Inc.

N/A

Current Price

$348.12

Market Cap

47.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
F
NTRA
Founded
1903
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
55.2B
47.4B
IPO Year
2008
2015

Fundamental Metrics

Financial Performance
Metric
F
NTRA
Price
$13.36
$348.12
Analyst Decision
Hold
Strong Buy
Analyst Count
13
15
Target Price
$13.41
$259.07
AVG Volume (30 Days)
36.3M
1.0M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
4.90%
N/A
EPS Growth
N/A
0.65
EPS
0.63
N/A
Revenue
$184,992,000,000.00
$210,939,000.00
Revenue This Year
N/A
$18.08
Revenue Next Year
$1.23
$19.65
P/E Ratio
$21.44
N/A
Revenue Growth
5.00
N/A
52 Week Low
$11.11
$157.43
52 Week High
$17.78
$343.18

Technical Indicators

Market Signals
Indicator
F
NTRA
Relative Strength Index (RSI) 42.46 70.58
Support Level $13.26 $187.64
Resistance Level $14.35 N/A
Average True Range (ATR) 0.41 10.20
MACD -0.04 -0.26
Stochastic Oscillator 23.83 97.21

Price Performance

Historical Comparison
F
NTRA

About F Ford Motor Company

Ford Motor Co. manufactures automobiles under its Ford and Lincoln brands. In March 2022, the company announced that it will run its combustion engine business, Ford Blue, and its BEV business, Ford Model e, as separate businesses but still all under Ford Motor. The company has over 13% market share in the United States, about 10% share in the UK, and just over 1% share in China including Taiwan and unconsolidated affiliates. Sales in the US made up about 65% of 2025 total company revenue. Ford has about 169,000 employees, including about 56,300 UAW employees, and is based in Dearborn, Michigan.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: